Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome

Pollak, 1961, Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis, J Lab Clin Med, 57, 495 Pollak, 1964, The natural history of the renal manifestations of systemic lupus erythematosus, J Lab Clin Med, 63, 537 Baldwin, 1970, The clinical course of the proliferative and membranous forms of lupus nephritis, Ann Intern Med, 73, 929, 10.7326/0003-4819-73-6-929 Zweiman, 1968, The prognosis of lupus nephritis. Role of clinical-pathologic correlations, Ann Intern Med, 69, 441, 10.7326/0003-4819-69-3-441 Estes, 1971, The natural history of systemic lupus erythematosus by prospective analysis, Medicine, 50, 85, 10.1097/00005792-197103000-00001 Cheatum, 1973, Renal histology and clinical course of systemic lupus erythematosus: a prospective study, Arthritis Rheum, 16, 670, 10.1002/art.1780160512 Baldwin, 1977, Lupus nephritis: clinical course as related to morphologic forms and their transitions, Am J Med, 62, 12, 10.1016/0002-9343(77)90345-X Appel, 1978, Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification, Medicine, 57, 371, 10.1097/00005792-197809000-00001 Hecht, 1976, Prognostic indices in lupus nephritis, Medicine, 55, 163, 10.1097/00005792-197603000-00005 Fish, 1977, Systemic lupus erythematosus within the first two decades of life, Am J Med, 62, 99, 10.1016/0002-9343(77)90355-2 Fries, 1978, Marginal benefit of renal biopsy in systemic lupus erythematosus, Arch Intern Med, 138, 1386, 10.1001/archinte.1978.03630340056018 Cameron, 1979, Systemic lupus with nephritis: a longterm study, Q J Med, 48, 1 Ballou, 1980, Prognostic value of clinical and renal biopsy findings in lupus nephritis, Clin Res, 28, 339A Wallace, 1982, Lupus nephritis: experience with 230 patients in a private practice from 1950 to 1980, Am J Med, 72, 209, 10.1016/0002-9343(82)90812-9 Whiting-O'Keefe, 1982, The information content from renal biopsy in systemic lupus erythematosus: step-wise linear regression analysis, Ann Intern Med, 96, 718, 10.7326/0003-4819-96-6-718 Decker, 1979, Systemic lupus erythematosus: evolving concepts, Ann Intern Med, 91, 587, 10.7326/0003-4819-91-4-587 Balow, 1981, Therapeutic trials in lupus nephritis: problems related to renal histology, monitoring of therapy and measures of outcome, Nephron, 27, 171, 10.1159/000182050 Steinberg, 1971, Cyclophosphamide in lupus nephritis: a controlled trial, Ann Intern Med, 75, 165, 10.7326/0003-4819-75-2-165 Steinberg, 1974, A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in treatment of lupus glomerulonephritis, Arthritis Rheum, 17, 923, 10.1002/art.1780170602 Decker, 1975, Cyclophosphamide or azathioprine in lupus glomerulonephritis: a controlled trial: results at 28 months, Ann Intern Med, 83, 606, 10.7326/0003-4819-83-5-606 Dinant, 1982, Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis, Ann Intern Med, 96, 728, 10.7326/0003-4819-96-6-728 Carette, 1983, Controlled studies of oral immunosuppressive drugs in lupus nephritis: a long-term follow-up, Ann Intern Med, 99, 1, 10.7326/0003-4819-99-1-1 Austin, 1983, Prognostic factors in lupus nephritis: contribution of renal histology, Am J Med, 75, 382, 10.1016/0002-9343(83)90338-8 Cohen, 1971, Preliminary criteria for the classification of systemic lupus erythematosus, Bull Rheum Dis, 21, 643 McCluskey, 1975, Lupus nephritis, 435 Pirani, 1968, Evaluation of percutaneous renal biopsy, Pathol Annu, 3, 249 Pirani, 1964, The reproducibility of semiquantitative analyses of renal histology, Nephron, 1, 230, 10.1159/000179336 Donadio, 1972, Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine, Ann Intern Med, 77, 829, 10.7326/0003-4819-77-6-829 Morel-Maroger, 1976, The course of lupus nephritis: contribution of serial renal biopsies, Adv Nephrol, 6, 79 Peto, 1976, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design, Br J Cancer, 34, 585, 10.1038/bjc.1976.220 Peto, 1977, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br J Cancer, 35, 1, 10.1038/bjc.1977.1 Lee, 1980, 75 Cox, 1974, 315 Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Gehan, 1965, A generalized Wilcoxon test for comparing arbitrarily singly-censored samples, Biometrika, 52, 203, 10.1093/biomet/52.1-2.203 Mantel, 1966, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep, 50, 163 Kalbfleisch, 1980, 15 Cox, 1972, Regression models and life tables, Royal Stat Soc, Series B, 34, 187 Muehrcke, 1957, Lupus nephritis: a clinical and pathological study based on renal biopsies, Medicine, 35, 1 Striker, 1973, The course of lupus nephritis: a clinical-pathological correlation of fifty patients, 1141 Mahajan, 1978, Changing histopathology patterns in lupus nephropathy, Clin Nephrol, 10, 1 Comerford, 1967, The nephropathy of systemic lupus erythematosus: an assessment by clinical, light and electron microscopic criteria, Medicine, 46, 425, 10.1097/00005792-196711000-00001 Nanra, 1973, Lupus nephritis: clinical course in relation to treatment, 1193 Hill, 1978, Systemic lupus erythematosus: morphologic correlations with immunologic and clinical data at the time of biopsy, Am J Med, 64, 61, 10.1016/0002-9343(78)90180-8 Ehrenreich, 1968, Pathology of membranous nephropathy, Pathol Ann, 3, 145